These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 26320154)
1. Resolvin E1 normalizes contractility, Ca2+ sensitivity and smooth muscle cell migration rate in TNF-α- and IL-6-pretreated human pulmonary arteries. Hiram R; Rizcallah E; Marouan S; Sirois C; Sirois M; Morin C; Fortin S; Rousseau E Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L776-88. PubMed ID: 26320154 [TBL] [Abstract][Full Text] [Related]
2. Resolvin D1 reverses reactivity and Ca2+ sensitivity induced by ET-1, TNF-α, and IL-6 in the human pulmonary artery. Hiram R; Rizcallah E; Sirois C; Sirois M; Morin C; Fortin S; Rousseau E Am J Physiol Heart Circ Physiol; 2014 Dec; 307(11):H1547-58. PubMed ID: 25281570 [TBL] [Abstract][Full Text] [Related]
3. Resolvin E1, resolvin D1 and resolvin D2 inhibit constriction of rat thoracic aorta and human pulmonary artery induced by the thromboxane mimetic U46619. Jannaway M; Torrens C; Warner JA; Sampson AP Br J Pharmacol; 2018 Apr; 175(7):1100-1108. PubMed ID: 29352769 [TBL] [Abstract][Full Text] [Related]
4. Docosahexaenoic acid monoacylglyceride decreases endothelin-1 induced Ca(2+) sensitivity and proliferation in human pulmonary arteries. Morin C; Fortin S; Rousseau E Am J Hypertens; 2012 Jul; 25(7):756-63. PubMed ID: 22534795 [TBL] [Abstract][Full Text] [Related]
5. Eicosapentaenoic acid ameliorates pulmonary hypertension via inhibition of tyrosine kinase Fyn. Kurahara LH; Hiraishi K; Yamamura A; Zhang Y; Abe K; Yahiro E; Aoki M; Koga K; Yokomise H; Go T; Ishikawa K; Bo Z; Kishi H; Kobayashi S; Aoki-Shoi N; Toru S; Inoue R; Hirano K J Mol Cell Cardiol; 2020 Nov; 148():50-62. PubMed ID: 32889002 [TBL] [Abstract][Full Text] [Related]
6. Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro. Salas-Hernández A; Espinoza-Pérez C; Vivar R; Espitia-Corredor J; Lillo J; Parra-Flores P; Sánchez-Ferrer CF; Peiró C; Díaz-Araya G Mol Biol Rep; 2021 Jan; 48(1):57-66. PubMed ID: 33459958 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of resolvin D1 and resolvin E1 on cementoblast function. Bozkurt SB; Hakki SS; Kantarci A J Periodontol; 2023 Nov; 94(11):1351-1362. PubMed ID: 37322861 [TBL] [Abstract][Full Text] [Related]
8. Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro. Rey C; Nadjar A; Buaud B; Vaysse C; Aubert A; Pallet V; Layé S; Joffre C Brain Behav Immun; 2016 Jul; 55():249-259. PubMed ID: 26718448 [TBL] [Abstract][Full Text] [Related]
9. Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration. Liu G; Gong Y; Zhang R; Piao L; Li X; Liu Q; Yan S; Shen Y; Guo S; Zhu M; Yin H; Funk CD; Zhang J; Yu Y FASEB J; 2018 Oct; 32(10):5413-5425. PubMed ID: 29723062 [TBL] [Abstract][Full Text] [Related]
10. Reversal of IL-13-induced inflammation and Ca(2+) sensitivity by resolvin and MAG-DHA in association with ASA in human bronchi. Khaddaj-Mallat R; Sirois C; Sirois M; Rizcallah E; Morin C; Rousseau É Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):145-54. PubMed ID: 26159746 [TBL] [Abstract][Full Text] [Related]
11. Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis. Ishida T; Yoshida M; Arita M; Nishitani Y; Nishiumi S; Masuda A; Mizuno S; Takagawa T; Morita Y; Kutsumi H; Inokuchi H; Serhan CN; Blumberg RS; Azuma T Inflamm Bowel Dis; 2010 Jan; 16(1):87-95. PubMed ID: 19572372 [TBL] [Abstract][Full Text] [Related]
12. Resolvin D1, but not resolvin E1, transactivates the epidermal growth factor receptor to increase intracellular calcium and glycoconjugate secretion in rat and human conjunctival goblet cells. Kaye R; Botten N; Lippestad M; Li D; Hodges RR; Utheim TP; Serhan CN; Dartt DA Exp Eye Res; 2019 Mar; 180():53-62. PubMed ID: 30513286 [TBL] [Abstract][Full Text] [Related]
13. Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. Tian H; Lu Y; Sherwood AM; Hongqian D; Hong S Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3613-20. PubMed ID: 19443724 [TBL] [Abstract][Full Text] [Related]
14. Resolvin E1 reduces proinflammatory markers in human pancreatic islets in vitro. Lund T; Mangsbo SM; Scholz H; Gjorstrup P; Tötterman TH; Korsgren O; Foss A Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):237-44. PubMed ID: 20119897 [TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-Potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma. Morin C; Fortin S; Cantin AM; Rousseau E Am J Respir Cell Mol Biol; 2011 Aug; 45(2):366-75. PubMed ID: 21057106 [TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Jin Y; Arita M; Zhang Q; Saban DR; Chauhan SK; Chiang N; Serhan CN; Dana R Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4743-52. PubMed ID: 19407006 [TBL] [Abstract][Full Text] [Related]
17. Resolvin E1 Attenuates Pulmonary Hypertension by Suppressing Wnt7a/β-Catenin Signaling. Liu G; Wan N; Liu Q; Chen Y; Cui H; Wang Y; Ren J; Shen X; Lu W; Yu Y; Shen Y; Wang J Hypertension; 2021 Dec; 78(6):1914-1926. PubMed ID: 34689593 [TBL] [Abstract][Full Text] [Related]
18. Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation. Qu X; Zhang X; Yao J; Song J; Nikolic-Paterson DJ; Li J J Pathol; 2012 Dec; 228(4):506-19. PubMed ID: 22610993 [TBL] [Abstract][Full Text] [Related]
19. Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse. Harrison JL; Rowe RK; Ellis TW; Yee NS; O'Hara BF; Adelson PD; Lifshitz J Brain Behav Immun; 2015 Jul; 47():131-40. PubMed ID: 25585137 [TBL] [Abstract][Full Text] [Related]
20. Proresolving Mediators LXB4 and RvE1 Regulate Inflammation in Stromal Cells from Patients with Shoulder Tendon Tears. Dakin SG; Colas RA; Wheway K; Watkins B; Appleton L; Rees J; Gwilym S; Little C; Dalli J; Carr AJ Am J Pathol; 2019 Nov; 189(11):2258-2268. PubMed ID: 31437425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]